Previous Close
$
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$448.8 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large...
Community
- 0 posts discussing
0
Watchers
0
Visitors